CCL2 and polycystic ovary syndrome: In our results, in addition to the considerable changes in metabolic indices, we observed ICAM-1, TNF-α and MCP-1 mRNA expression in OCP-treated PCOS women was increased to 2.54 fold, 2.05 fold and 1.74 fold, respectively, compared to drug-naive PCOS women.